Virtual reality boosts stroke rehab: better balance, better walking

NCT ID NCT07409116

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding virtual reality (VR) balance exercises to standard physical therapy helps stroke patients walk and keep their balance better. 34 people who had a stroke within the last 6 months took part. Some did only standard therapy, while others replaced 20% of their therapy with VR balance games using a headset. The goal was to see if the VR group improved more in walking speed, distance, and balance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Jan 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hemorrhagic or ischemic stroke within the past 6 months, * Minimum age of 18 years old, * Ability to stand and walk with or without assistance * Mini-Mental State Examination score of more than 15/30 * Ability to understand instructions, * No visual deficits hindering VR training and vi) a health status allowing for rehabilitation Exclusion Criteria: * other orthopedic or neurological disease altering the function of the paretic lower limb, balance or gait.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke patients are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Erasme University Hospital (Hôpital Universitaire de Bruxelles - H.U.B.)

    Brussels, 1070, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.